CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure Association of Cardiovascular Disease With Respiratory Disease Dapagliflozin for treating chronic heart failure with reduced ejection fraction AIM2-driven inflammasome activation in heart failure A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics.

Original ResearchVolume 3, Issue 5, October 2018

JOURNAL:JACC: Basic to Translational Science Article Link

Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors

S Verma, S Rawat, KL Ho et al. Keywords: cardiac efficiency; db/db; glucose oxidation; ketone oxidation; sodium-glucose co-transporter-2 inhibitors

FULL TEXT PDF